CB vs COLL
Chubb Ltd (CB) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CB currently screens at market cap $114.26B and trailing P/E 13.7. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CB and COLL stock pages for the full models.
Not investment advice.